SeraCare Life Sciences (SRLS) says it will explore and evaluate potential strategic alternatives...

|By:, SA News Editor

SeraCare Life Sciences (SRLS) says it will explore and evaluate potential strategic alternatives to enhance shareholder value, including a sale or other transaction, but there is no set timetable for making a decision. SRLS +3.3% premarket. (PR)